Evaluation of urine lipoarabinomannan and host response signatures for culture-negative tuberculosis using composite criteria and Bayesian Latent Class Analysis
Background: Culture-negative TB is a major diagnostic challenge, and the lack of a reliable reference standard hinders evaluation of non-sputum diagnostic tests. We compared composite reference criteria and Bayesian latent class analysis to examine how different culture-negative TB definitions affect disease classification and evaluations of two non-sputum biomarkers: urine lipoarabinomannan (uLAM) and host transcriptional response signatures (HRS). Methods: Urine and blood samples from 112 sputum culture-negative and 55 culture-positive symptomatic adults evaluated for tuberculosis from South Africa, Uganda, and Kenya, alongside 17 controls with other respiratory conditions, were analyzed using uLAM and HRS assays. Sensitivity and specificity were estimated for each assay based on three reference criteria: composite microbiological, composite clinical, and a latent class model. Results: Positive classification proportions were 0.29 (32/112) and 0.46 (51/112) for the composite criteria and 0.20 (22/112) for the latent class model, with the Bayesian model estimating a prevalence of 0.31 (95%CrI 0.11-0.64). Sensitivity and specificity for uLAM ranged from 0.06-0.13 and 0.92-0.96, respectively. Sensitivity and specificity for HRS ranged from 0.47-0.78 and 0.56-0.69, respectively. uLAM results were significantly associated with microbiological positivity (OR=5.38, 95%CI=1.63-13.02). Conclusion: Three distinct reference frameworks identified different individuals as having culture-negative TB while producing index assay sensitivity and specificity estimates with overlapping confidence and credible intervals, leading to similar conclusions regarding biomarker utility. This supports the use of complementary reference approaches to assess robustness to disease classification uncertainty in heterogeneous conditions such as culture-negative TB.
Authors
- Ian Schiller
- Yingda Linda Xie (ORCID: https://orcid.org/0000-0001-5587-4731)
- William Evan Johnson (ORCID: https://orcid.org/0000-0002-6247-6595)
- Christie Eichberg (ORCID: https://orcid.org/0000-0002-6501-6295)
- Padmini Salgame (ORCID: https://orcid.org/0000-0003-2245-3767)
- Chad Centner
- Abraham Pinter (ORCID: https://orcid.org/0000-0002-3262-3304)
- Ellner Jerrold
- Vaishnavi Kaipilyawar (ORCID: https://orcid.org/0000-0002-8940-8509)
- Robert Reiss (ORCID: https://orcid.org/0000-0002-1131-0907)
- Kattya Lopez (ORCID: https://orcid.org/0000-0002-7032-281X)
- Nandini Dendukuri (ORCID: https://orcid.org/0000-0002-2330-0976)
- Lydia Nakiyingi (ORCID: https://orcid.org/0000-0001-7263-3198)
- Susan Dorman
- N Modi (ORCID: https://orcid.org/0009-0006-4243-9742)
- Lesly Suarez Caceres
- William Honnen
Institutions
- Rutgers, The State University of New Jersey (US)
- Medical University of South Carolina (US)
- University of Cape Town (ZA)
- Rutgers New Jersey Medical School (US)
- Research Institute of the McGill University Health Centre (CA)
- Makerere University (UG)
Publication Details
- Journal
- medRxiv
- Published
- 2026-11-20
- DOI
- https://doi.org/10.64898/2026.11.18.26368340
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- preprint
Funders
- Bill and Melinda Gates Foundation
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases